Indications to respiratory syncytial virus immunoprophylaxis in the 29–32 wGA group: is there still room for debating?

Guidelines on immunoprophylaxis for prevention of RSV infection recommend it in preterm babies born before 29 wGA; in babies affected by bronchopulmonary dysplasia or congenital heart defects; and in post-heart transplantation patients. On the contrary, immunoprophylaxis is not recommended in preter...

Descripción completa

Detalles Bibliográficos
Autores principales: Zuccotti, Gianvincenzo, Fabiano, Valentina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5347811/
https://www.ncbi.nlm.nih.gov/pubmed/28257653
http://dx.doi.org/10.1186/s13052-017-0341-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5347811/
https://www.ncbi.nlm.nih.gov/pubmed/28257653
http://dx.doi.org/10.1186/s13052-017-0341-4

Ejemplares similares